The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study results of JNJ-78278343 (pasritamig) in metastatic castration-resistant prostate cancer (mCRPC).
 
Capucine Baldini
Consulting or Advisory Role - Bicycle Therapeutics; Janssen Oncology; Janssen Oncology; Rising Tide Foundation
Research Funding - Foundation BMS (Inst); Foundation BMS (Inst)
Expert Testimony - Abbvie; AstraZeneca; Bristol-Myers Squibb; MSD Oncology; MSD Oncology
Travel, Accommodations, Expenses - Amgen; Janssen Oncology; MSD Oncology; Roche/Genentech
 
Armelle Vinceneux
Consulting or Advisory Role - AAA/Endocyte/Novartis; Ipsen; Loxo/Lilly; Pfizer
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; MSD Oncology; Pfizer
 
Debbie Robbrecht
Honoraria - Springer
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Axiom Healthcare Strategies; BMS; Gilead Sciences (Inst); J&J (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst)
Research Funding - Merck KGaA (Inst)
 
Bernard Doger de Spéville
No Relationships to Disclose
 
Karen Autio
Honoraria - MashupMedia
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Janux Therapeutics (Inst); Pfizer (Inst)
 
Michael Schweizer
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; FibroGen; Janssen; Pfizer; Sanofi
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Epigenetix (Inst); Immunomedics (Inst); Incyte (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SignalOne Bio (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst); Zenith Epigenetics (Inst)
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - BeiGene; European Organisation for Research and Treatment of Cancer (EORTC); Merus NV; Novartis; PharmaMar; Sanofi; START
Stock and Other Ownership Interests - Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Adcendo; Amunix; Anaveon; AstraZeneca/MedImmune; Bristol-Myers Squibb; Chugai Pharma; Diaccurate; Elevation Oncology; Ellipses Pharma; Genmab; Janssen-Cilag; MonTa Biosciences; MSD Oncology; Nanobiotix; Nouscom; Novartis; OncoDNA; PharmaMar; Roche/Genentech; Servier; Syneos Health; T-Knife; TargImmune Therapeutics
Research Funding - START
Other Relationship - CRIS Cancer Foundation; Foundation PharmaMar; Investigational Therapeutics in Oncological Sciences
 
Laura Medina Rodriguez
Consulting or Advisory Role - Novartis, Servier, Merck
Travel, Accommodations, Expenses - Novartis, Servier, Merck
 
Marloes Dongen
No Relationships to Disclose
 
Jean-Laurent Deville
Travel, Accommodations, Expenses - Pfizer
 
Alice Bernard-Tessier
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bouchara Recordati; Janssen; MSD; Novartis (Inst); Orion Clinical; Roche
Travel, Accommodations, Expenses - AAA/Endocyte/Novartis; Bayer; Orion Clinical
 
Debopriya Ghosh
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Kristin Shotts
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Pharavee Jaiprasart
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Leanne Cartee
Employment - Johnson & Johnson
Stock and Other Ownership Interests - GlaxoSmithKline; Johnson & Johnson
 
Daria Gaut
Employment - Genentech, Johnson & Johnson
Stock and Other Ownership Interests - Genentech, Johnson & Johnson
Travel, Accommodations, Expenses - Genentech, Johnson & Johnson
 
Josh Lauring
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - Abbvie (I); Galderma (I)
Speakers' Bureau - Abbvie (I); Boehringer Ingelheim (I); Bristol-Myers Squibb/Celgene (I); Dermavant (I); Galderma (I); Lilly (I)
Patents, Royalties, Other Intellectual Property - I intermittently receive royalty payments for cell lines created in my laboratory which are licensed for commercial sale to Horizon Discovery, Ltd by Johns Hopkins University.
Travel, Accommodations, Expenses - Abbvie (I); Boehringer Ingelheim (I); Dermavant (I); Galderma (I); Lilly (I)
 
Sherry Wang
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson; Pfizer
Consulting or Advisory Role - Convergent Laser (I)
Patents, Royalties, Other Intellectual Property - Medical devices (I)
 
Victor Villalobos
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Mark Stein
Stock and Other Ownership Interests - Rafael Holdings
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Bristol-Myers Squibb/Medarex; Exelixis; Exelixis; Janssen Oncology; Merck Sharp & Dohme; Regeneron (Inst); Repare Therapeutics (Inst); Vaccitech; Xencor
Research Funding - Advaxis (Inst); AstraZeneca (Inst); Bellicum Pharmaceuticals; Bicycle Therapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genocea Biosciences (Inst); Harpoon (Inst); Janssen Oncology (Inst); Lilly (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Nektar (Inst); Oncoceutics (Inst); Regeneron (Inst); Seagen (Inst); Suzhou Kintor Pharmaceuticals (Inst); Tmunity Therapeutics, Inc. (Inst); Xencor (Inst)